{
    "clinical_study": {
        "@rank": "168270", 
        "acronym": "SEVOKID", 
        "arm_group": {
            "arm_group_label": "sevoflurane", 
            "arm_group_type": "Experimental", 
            "description": "Determination of plasmatic concentrations of sevoflurane at different times of a 48h sedation of sevoflurane in ICU patients with acute kidney injury"
        }, 
        "brief_summary": {
            "textblock": "Describing a pharmacokinetic model of 48-h sevoflurane sedation in ICU patients with acute\n      kidney failure"
        }, 
        "brief_title": "Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa\u00a9) in ICU Patients With Acute Kidney Injury", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Prospective clinical monocentric study in ICU with sedated ventilated patients (presenting\n      acute kidney failure) with sevoflurane during 48 h with the AnaConda\u00ae system, establishing\n      pharmacokinetic model of sevoflurane and its metabolites (hydroxyfluroisopropanol, fluoride)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Adult patients ventilated more than 48 h Stable respiratory and hemodynamic conditions\n        Consent of patients or family Arterial line AKIN score = 3\n\n        Exclusion Criteria:\n\n          -  BMI <30 Sevoflurane anaphylaxia"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02042599", 
            "org_study_id": "CHU-0175", 
            "secondary_id": "2012-005746-37"
        }, 
        "intervention": {
            "arm_group_label": "sevoflurane", 
            "intervention_name": "Sedation with sevoflurane during 48-hr in ICU", 
            "intervention_type": "Drug", 
            "other_name": "Determination of plasmatic concentrations of sevoflurane at different times of a 48h sedation of sevoflurane in ICU patients with acute kidney injury"
        }, 
        "intervention_browse": {
            "mesh_term": "Sevoflurane"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pharmacokinetics", 
            "Sevoflurane", 
            "Acute kidney injury", 
            "Sedation", 
            "ICU patients"
        ], 
        "lastchanged_date": "January 22, 2014", 
        "location": {
            "contact": {
                "email": "placarin@chu-clermontferrand.fr", 
                "last_name": "Patrick LACARIN", 
                "phone": "04 73 75 11 95"
            }, 
            "facility": {
                "address": {
                    "city": "Clermont-Ferrand", 
                    "country": "France", 
                    "zip": "63003"
                }, 
                "name": "CHU de Clermont-Ferrand"
            }, 
            "investigator": [
                {
                    "last_name": "Daniel BOURDEAUX", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Etienne BAZIN", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jean-Michel CONSTANTIN", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa\u00a9) in ICU Patients With Acute Kidney Injury", 
        "overall_contact": {
            "email": "placarin@chu-clermontferrand.fr", 
            "last_name": "Patrick LACARIN", 
            "phone": "04 73 75 11 95"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Clermont-Ferrand", 
            "last_name": "S\u00e9bastien PERBET", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Determination of plasmatic concentrations of sevoflurane before using AnaConda\u00ae system", 
            "safety_issue": "Yes", 
            "time_frame": "at 5min,  60 min, 24 hrs and just before the end of sedation."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02042599"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Determination of plasmatic concentrations of HFIP and fluoride", 
            "safety_issue": "Yes", 
            "time_frame": "at 5min, 15 min, 60 min and just before the end of sedation. And 5 min, 10 min, 30 min, 120 min and 360 min after the end of sedation"
        }, 
        "source": "University Hospital, Clermont-Ferrand", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Clermont-Ferrand", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}